WESAIL WESAIL
  • Home
  • About us
  • Products
    Fluorescence Immunoassay (FIA) Chemiluminescence Immunoassay (CLIA) Rapid Test (Colloidal gold) Quality Control
  • Solution
    Chest Pain Center Stroke Center Trauma Center Critical Maternal Care Center Critical Children and Neonatal Care Center Center for Reproductive Medicine Hierarchical diagnosis and treatment Hospital-wide solution
  • News
  • User Services
  • Join us
  • 中文
  • +86 -755-23577939
  • 
  • 中文 English
WESAIL
  • Home
  • About us
  • Products

    Fluorescence Immunoassay (FIA)

    Chemiluminescence Immunoassay (CLIA)

    Rapid Test (Colloidal gold)

    Quality Control

  • Solution

    Chest Pain Center

    Stroke Center

    Trauma Center

    Critical Maternal Care Center

    Critical Children and Neonatal Care Center

    Center for Reproductive Medicine

    Hierarchical diagnosis and treatment

    Hospital-wide solution

  • News
  • User Services
  • Join us
  • 中文
  • CN

News Center
News Center
  • Home page
All categories

Notification publicity
Market Activity
Company Dynamics

Oct 29,2024

2024.7~2024.9 Solid Waste Pollution Prevention and Control Information Disclosure


2024.7~2024.9 Solid Waste Pollution Prevention and Control Information Disclosure

Oct 29,2024

2024.4~2024.6 Solid Waste Pollution Prevention and Control Information Disclosure


2024.4~2024.6 Solid Waste Pollution Prevention and Control Information Disclosure

Dec 06,2021

Information Disclosure of Hazardous Waste Generating Units


In accordance with relevant laws and regulations, our company is now disclosing hazardous waste information from the first to the third quarter of 2021.

Information Disclosure of Hazardous Waste Generating Units

Aug 30,2022

2021.10~2022.6 Solid Waste Pollution Prevention and Control Information Disclosure


2021.10~2022.6 Solid Waste Pollution Prevention and Control Information Disclosure

Nov 08,2022

Solid waste pollution prevention and control information disclosure in 2022 (third quarter)


Solid waste pollution prevention and control information disclosure in 2022 (third quarter)

Dec 12,2022

Statement


Statement
< 1 > proceed page
Picture Name
  • Home

  • About us

  • Products

    • Fluorescence Immunoassay (FIA)

      • Reagent

      • Analyzers

    • Chemiluminescence Immunoassay (CLIA)

      • Reagent

      • Instrument

    • Rapid Test (Colloidal gold)

    • Quality Control

      • Cardiac markers

      • Thrombus

      • Inflammation

      • Renal function

      • Thyroid function

      • Diabetes

      • Bone metabolism

      • Gastric function

      • Pregnancy

      • Reproductive function

      • Anemia

      • Other

  • Solution

    • Chest Pain Center

    • Stroke Center

    • Trauma Center

    • Critical Maternal Care Center

    • Critical Children and Neonatal Care Center

    • Center for Reproductive Medicine

    • Hierarchical diagnosis and treatment

    • Hospital-wide solution

  • News

  • User Services

  • Join us

  • 中文

Telephone:4009001339
Mail:customer-cn@wesailbio.com
Address: Room 403, Building 1, No.1 Taoyuan Road, Songshan Lake Park, Dongguan City, Guangdong Province

facebook
Instagram
youtube

©COPYRIGHT 2023 Guangdong Weishi Biotechnology Co., Ltd. ALL RIGHTS RESERVED Website Construction:China Enterprise Power  Shenzhen   SEO

Business License

©COPYRIGHT 2023 Guangdong Weishi Biotechnology Co., Ltd.

Website construction:China Enterprise Power Shenzhen  SEO

Skype

4

Skype

12321321

E-mail

8

E-mail

customer-cn@wesailbio.com

Tel

9

Tel

4009001339